Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs ABRDN Physical Gold Shares ETF (SGOL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs ABRDN Physical Gold Shares ETF — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while ABRDN Physical Gold Shares ETF trades at $39.92 (market cap $7.03B). The key difference: ABRDN Physical Gold Shares ETF is the larger of the two by market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, ABRDN Physical Gold Shares ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and ABRDN Physical Gold Shares ETF for 57 Days on average.
| IOVA | SGOL | |
|---|---|---|
Market Cap | $6.04B | $7.03B |
Volume | 14,805,993 | 2,350,550 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $14.82 | $51.41 |
52-Week Low | $1.81 | $37.54 |
Typical Hold Time | 0 Days | 57 Days |
Enterprise Value | $5.97B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SGOL trades at $39.31, up 0.74% today, while technical indicators show a bearish bias with moving averages and ADX signaling sell conditions. The stock lacks key financial ratio data such as P/E and P/B, limiting fundamental clarity. Recent gold-related news highlights pressure from rising Treasury yields and a firm dollar, though softer inflation data has provided some support.
The outlook remains cautious due to macroeconomic headwinds and incomplete financial disclosures. Risks include interest rate sensitivity and gold price volatility. Investors should seek updated SEC filings for fundamental metrics before considering a position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About ABRDN Physical Gold Shares ETF
SGOL is an ETF that is designed to track the performance of the price of gold bullion. The fund is backed by physical gold held in secured vaults, which is allocated to the ETF's custodian account. By providing direct ownership of gold without the need for physical storage or insurance, SGOL offers investors a convenient and cost-effective way to gain exposure to the gold market.
Read more on SGOL →
